Novavax News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

21.02.22	Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights on February 28, 2022 (PR Newswire)
17.02.22	Health Canada Authorizes Novavax COVID-19 Vaccine (PR Newswire)
14.02.22	Singapore Health Sciences Authority Issues Interim Authorization for Novavax COVID-19 Vaccine (PR Newswire)
14.02.22	Novavax Files For Conditional CMA Of COVID-19 Vaccine In Switzerland - Quick Facts (RTTNews)
14.02.22	Novavax Files for Conditional Marketing Authorization of COVID-19 Vaccine in Switzerland (PR Newswire)
11.02.22	Novavax to Participate in Fireside Chat at the 11th Annual SVB Leerink Global Healthcare Conference (PR Newswire)
10.02.22	Novavax Reports Positive Results Of COVID-19 Vaccine In Pediatric Population Of Phase 3 Trial (RTTNews)
10.02.22	Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial (PR Newswire)
04.02.22	New Zealand Grants Provisional Approval For Novavax' COVID-19 Vaccine (RTTNews)
03.02.22	New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine (PR Newswire)
03.02.22	U.K. Grants Conditional Marketing Authorization For Novavax's COVID-19 Vaccine (RTTNews)
03.02.22	Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine in Great Britain* (PR Newswire)
31.01.22	Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine (PR Newswire)
28.01.22	Novavax Inks Advance Purchase Deal For Supply Of COVID-19 Vaccine To Israel - Quick Facts (RTTNews)
28.01.22	Novavax and Israel Announce Advance Purchase Agreement for Supply of COVID-19 Vaccine (PR Newswire)
20.01.22	Australia Grants Provisional Approval For Novavax COVID-19 Vaccine (RTTNews)
20.01.22	Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine (PR Newswire)
12.01.22	Novavax: South Korea Approves Nuvaxovid COVID-19 Vaccine (RTTNews)
12.01.22	South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine (PR Newswire)
10.01.22	NVAX FINAL DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Novavax, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important January 11 Deadline in Securities C... (PR Newswire)
10.01.22	Novavax, Serum File For Emergency Use Authorization Of COVID-19 Vaccine Candidate In South Africa (RTTNews)
10.01.22	Novavax and Serum Institute of India File for Emergency Use Authorization of Novavax' COVID-19 Vaccine in South Africa (PR Newswire)
05.01.22	NVAX FINAL DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Novavax, Inc. Investors With Losses to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAX (PR Newswire)
04.01.22	Novavax to Participate in the 40th Annual J.P. Morgan Healthcare Conference (PR Newswire)
31.12.21	Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine (PR Newswire)
29.12.21	FINAL DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Novavax, Inc. Investors with Losses to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAX (PR Newswire)
28.12.21	Novavax Receives Emergency Use Authorization For COVID-19 Vaccine In India (RTTNews)
28.12.21	Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India (PR Newswire)
24.12.21	SK Bioscience Secures Long-term License To Supply NVX-CoV2373 For Korean Market (RTTNews)
24.12.21	Novavax and SK bioscience Expand Manufacturing Agreement (PR Newswire)
22.12.21	Novavax Gains 5% After Covid Vaccine Study Shows "Strong Immune Response" Against Omicron Variant (RTTNews)
22.12.21	Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies (PR Newswire)
22.12.21	WHO Panel Recommends Third Dose Of Novavax COVID-19 Vaccine For Immunocompromised Persons (RTTNews)
22.12.21	Novavax Initiates COVID-19 Vaccine Phase 3 Trial Booster Study (RTTNews)
21.12.21	Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study (PR Newswire)
21.12.21	World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine (PR Newswire)
21.12.21	ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Novavax, Inc. Investors With Losses to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAX (PR Newswire)
21.12.21	Pre-market Movers: ARDS, RELI, ALDX, QNRX, AQST… (RTTNews)
20.12.21	World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine (PR Newswire)
20.12.21	European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine (PR Newswire)
20.12.21	EMA Recommends Conditional Marketing Authorization For Novavax COVID-19 Vaccine For Adults (RTTNews)
20.12.21	Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine (PR Newswire)
20.12.21	Pre-market Movers: SOPA, VRS, ITCI, IMMX, SPRB… (RTTNews)
17.12.21	Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine (PR Newswire)
16.12.21	Novavax: Partner Takeda Submits NDA In Japan For Approval Of COVID-19 Vaccine (RTTNews)
16.12.21	Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine (PR Newswire)
14.12.21	ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Novavax, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - NVAX (PR Newswire)
13.12.21	Novavax Files For Emergency Use Of COVID-19 Vaccine NVX-CoV2373 In UAE - Quick Facts (RTTNews)
13.12.21	Novavax Files for Emergency Use of COVID-19 Vaccine in the United Arab Emirates (PR Newswire)
02.12.21	NVAX LOSS ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Novavax, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVAX (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

07:45		Novartis-Aktie: EU-Zulassung für Kisqali bei Brustkrebs im Frühstadium
26.11.24		Zuversicht in New York: Zum Handelsende Gewinne im NASDAQ 100
26.11.24		Dow Jones aktuell: Dow Jones zum Handelsende in Grün
26.11.24		Börse New York: Dow Jones wenig verändert
26.11.24		Starker Wochentag in New York: NASDAQ 100-Anleger greifen am Nachmittag zu
26.11.24		Optimismus in New York: NASDAQ 100 mittags freundlich
26.11.24		Verluste in New York: Dow Jones legt den Rückwärtsgang ein
26.11.24		Schwache Performance in Europa: Euro STOXX 50 schlussendlich leichter